0000000001010957

AUTHOR

Maurizio Ceruti

showing 6 related works from this author

Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as inhibitors of liver and yeast oxidosqualene cyclase

2002

The synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives is described starting from the C22 and C17 squalene aldehyde monobromohydrins. The conversion was achieved by means of a Wittig reaction, followed by desilylation of the terminal acetylene. For trisubstituted 1,3-enynes, preliminary alkylation with a suitable allyl bromide was performed. A new procedure for the synthesis of squalene aldehyde C27, C22 and C17 monobromohydrins is also described. Some of the new compounds behaved as inhibitors of pig liver and yeast oxidosqualene cyclase and were time-dependent inhibitors of the animal enzyme.

chemistry.chemical_classificationAllyl bromideoxidosqualene derivatives; oxidosqualene cyclase; squaleneStereochemistryAlkylationsqualeneAldehydeYeast23-Oxidosqualenechemistry.chemical_compoundSqualeneEnzymechemistryWittig reactionoxidosqualene cyclaselipids (amino acids peptides and proteins)oxidosqualene derivatives
researchProduct

ChemInform Abstract: Synthesis of (E)- and (Z)-29-Methylidyne-2,3-oxidosqualene Derivatives as Inhibitors of Liver and Yeast Oxidosqualene Cyclase.

2010

The synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives is described starting from the C22 and C17 squalene aldehyde monobromohydrins. The conversion was achieved by means of a Wittig reaction, followed by desilylation of the terminal acetylene. For trisubstituted 1,3-enynes, preliminary alkylation with a suitable allyl bromide was performed. A new procedure for the synthesis of squalene aldehyde C27, C22 and C17 monobromohydrins is also described. Some of the new compounds behaved as inhibitors of pig liver and yeast oxidosqualene cyclase and were time-dependent inhibitors of the animal enzyme.

chemistry.chemical_classificationAllyl bromideStereochemistryGeneral MedicineAlkylationAldehydeYeast23-Oxidosqualenechemistry.chemical_compoundSqualeneEnzymechemistryWittig reactionlipids (amino acids peptides and proteins)ChemInform
researchProduct

Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy

2014

This paper deal with the synthesis and characterization of PEGylated squalene-grafted-inulin amphiphile capable of self-assembling and self-organizing into nanocarriers once placed in aqueous media. It was exploited as coating agent for obtaining doxorubicin loaded superparamagnetic iron oxide nanoparticles (SPIONs) endowed with stealth like behavior and excellent physicochemical stability. Inulin was firstly modified in the side chain with primary amine groups, followed in turn by conjugation with squalenoyl derivatives through common amidic coupling agents and PEGylation by imine linkage. Polymer coated SPIONs were so obtained by spontaneous self-assembling of inulin copolymer onto magnet…

Hydrodynamic radiusCell SurvivalPolymersSurface PropertiesPharmaceutical ScienceTherapeutic indexSpectroscopy Fourier Transform InfraredAmphiphileZeta potentialmedicineSPIONs Inulin copolymer Doxorubicin Magnetic targeting Squalene PegylatedHumansOrganic chemistryDoxorubicinParticle SizeMagnetite NanoparticlesDrug CarriersAntibiotics AntineoplasticMolecular StructureChemistryInulinGeneral MedicineHCT116 CellsCombinatorial chemistryDrug LiberationDoxorubicinDrug deliveryMicroscopy Electron ScanningPEGylationNanocarriersBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells

2012

A novel polysorbate-80 (PS(80))-attached amphiphilic copolymer comprising a hydrophilic α,β-poly(N-2-hydroxyethyl)-D,L-aspartamide (PHEA) backbone and hydrophobic squalenyl-C(17) (Sq(17)) portions was synthesized and characterized; the formation of polymeric micelles was also evaluated. Rivastigmine free-base (Riv), a hydrophobic drug employed to treat Alzheimer's disease, was chosen as model drug to investigate micelle's ability to incorporate hydrophobic molecules and target them to neuronal cells. Micelle formation was studied through analyses including fluorescence spectroscopy and 2D (1)H-NMR NOESY experiments. Finally, the capacity of Riv-loaded micelles, versus free drug, to penetrat…

Materials sciencePhenylcarbamatesPharmaceutical ScienceRivastigminepolyaspartamide micelles rivastigmine drug delivery neuronal cellsMicelleFluorescence spectroscopyHydrophobic effectMiceNeuroblastomachemistry.chemical_compoundDrug Delivery SystemsCell Line TumorAmphiphileCopolymerAnimalsHumansOrganic chemistryParticle SizeMicellesAlkylNeuronschemistry.chemical_classificationPolysorbateDrug CarriersGeneral MedicineHydrophobeNeuroprotective AgentsSpectrometry FluorescencechemistryBiophysicsPeptidesHydrophobic and Hydrophilic InteractionsDrug Delivery
researchProduct

Biocompatible micelles based on squalene portions linked to pegylated polyaspartamide as potential colloidal drug carriers

2011

Materials scienceBiomedical EngineeringPharmaceutical ScienceMedicine (miscellaneous)BioengineeringBiocompatible materialMicelleSqualenechemistry.chemical_compoundColloidchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoOrganic chemistryDrug carrieramphiphilic copolymers drug carriers micelles αβ-poly(N-2-hydroxyethyl)-DLaspartamidesqualene in vitro uptakeBiotechnology
researchProduct

NOVEL AMPHIPHILIC COPOLYMERS BASED ON POLYASPARTAMIDE GRAFT WITH SQUALENE RESIDUES TO OBTAIN MICELLES AS COLLOIDAL DRUG CARRIERS.

2009

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoPHEA SQUALENE MICELLES DRUG CARRIERS.
researchProduct